1999
DOI: 10.1016/s0264-410x(99)00055-9
|View full text |Cite
|
Sign up to set email alerts
|

Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection1Presented at the 4th Conference on Retroviruses and Opportunistic Infections, 22–26 January 1997 (Abstract 696) in Washington, DC.1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…We excluded 43 studies some of which were non-randomised (Abzug 2009; Alaei 2003; Bailey 2008; Carne 1987; Horster 2010; Kalinowska-Nowak 2007; Koblin 1999; Lao-Araya 2011; Loke 1990; Paitoonpong 2008; Sellar 2009; Thaithumyanon 2002; Wilson 2001; Wursthorn 2011), not in PLHIV (Altuntas 2011; Mehta 2010; Mehta 2010a; Miller 1989; Odaka 1988; Pasricha 2005; Thompson 1998) testing adjuvants to hepatitis B vaccine (Cooper 2005a; Cooper 2008; Overton 2010; Overton 2011; Sasaki 2003; Sayad 2012); testing modalities of administering hepatitis B vaccine (Bunupuradah 2011; de Vries-Sluijs 2011; Flynn 2011; Fonseca 2005; Hwang 2010; Launay 2011; McQuillan 2010) vaccines targeting other conditions (Johnson 1999; Kintu 2013; Launay 2011a). See Characteristics of excluded studies.…”
Section: Resultsmentioning
confidence: 99%
“…We excluded 43 studies some of which were non-randomised (Abzug 2009; Alaei 2003; Bailey 2008; Carne 1987; Horster 2010; Kalinowska-Nowak 2007; Koblin 1999; Lao-Araya 2011; Loke 1990; Paitoonpong 2008; Sellar 2009; Thaithumyanon 2002; Wilson 2001; Wursthorn 2011), not in PLHIV (Altuntas 2011; Mehta 2010; Mehta 2010a; Miller 1989; Odaka 1988; Pasricha 2005; Thompson 1998) testing adjuvants to hepatitis B vaccine (Cooper 2005a; Cooper 2008; Overton 2010; Overton 2011; Sasaki 2003; Sayad 2012); testing modalities of administering hepatitis B vaccine (Bunupuradah 2011; de Vries-Sluijs 2011; Flynn 2011; Fonseca 2005; Hwang 2010; Launay 2011; McQuillan 2010) vaccines targeting other conditions (Johnson 1999; Kintu 2013; Launay 2011a). See Characteristics of excluded studies.…”
Section: Resultsmentioning
confidence: 99%